Free Trial
NASDAQ:TNFA

TNF Pharmaceuticals (TNFA) Stock Price, News & Analysis

TNF Pharmaceuticals logo
$0.20 +0.00 (+0.05%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.20 -0.01 (-2.58%)
As of 05/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About TNF Pharmaceuticals Stock (NASDAQ:TNFA)

Key Stats

Today's Range
$0.20
$0.24
50-Day Range
$0.17
$0.44
52-Week Range
$0.16
$2.16
Volume
3.49 million shs
Average Volume
552,884 shs
Market Capitalization
$2.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TNF Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Receive TNFA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TNF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TNFA Stock News Headlines

TNF Pharmaceuticals (TNFA) & Its Competitors Head to Head Comparison
The Man I Turn to In Times Like This
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.
TNF Pharmaceuticals (TNFA) and The Competition Financial Contrast
Financial Comparison: TNF Pharmaceuticals (TNFA) & Its Peers
See More Headlines

TNFA Stock Analysis - Frequently Asked Questions

TNF Pharmaceuticals' stock was trading at $1.15 at the start of the year. Since then, TNFA shares have decreased by 82.5% and is now trading at $0.2012.
View the best growth stocks for 2025 here
.

TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) issued its quarterly earnings data on Friday, April, 11th. The company reported ($0.66) EPS for the quarter.

Shares of TNFA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TNF Pharmaceuticals investors own include Amprius Technologies (AMPX), Archrock (AROC), Axon Enterprise (AXON), PACCAR (PCAR), Bitfarms (BITF), Bitfarms (BFARF) and BigBear.ai (BBAI).

Company Calendar

Last Earnings
4/11/2025
Today
5/02/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TNFA
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$7.21 per share
Price / Book
0.03

Miscellaneous

Free Float
2,722,000
Market Cap
$2.04 million
Optionable
N/A
Beta
2.43
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:TNFA) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners